Tag: pharmaceuticals

  • Pharmas, Foundations, Agencies Partner on Tropical Diseases

    In London yesterday, the Bill & Melinda Gates Foundation, 13 pharmaceutical companies, three governments, the World Bank and global health agencies announced a new plan to eliminate or control 10 neglected tropical diseases (NTDs) by 2020. The effort announced at an event at the Royal College of Physicians is aimed at 1.4 billion people living…

  • FDA Approves Genentech Skin Cancer Drug

    The Food and Drug Administration today approved the drug vismodegib to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug, marketed under the brand name Erivedge by Genentech in South San Francisco, is intended for use in patients with locally advanced basal cell cancer who are not candidates…

  • NIH Trials to Assess Emergency Cardiac Arrest Treatments

    NIH’s National Heart, Lung, and Blood Institute has begun two clinical trials to evaluate treatments for out-of-hospital cardiac arrest: – A comparison of continuous chest compressions (CCC) combined with pause-free rescue breathing, to standard cardiopulmonary resuscitation (CPR) that includes a combination of chest compressions and pauses for rescue breathing, and – Treatment with the drug…

  • Celgene to Acquire Avila Therapeutics

    The pharmaceutical company Celgene Corp. in Summit, New Jersey says it will acquire Avila Therapeutics, a biotechnology company in Bedford, Massachusetts. Celgene discovers and commercializes therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. Avila develops covalent drugs, those that bind to and inhibit disease-causing proteins. Under the agreement, Celgene…

  • Dutch Biotech Raises $30M for Rare Disease Therapies

    Prosensa, a biopharmaceutical company in Leiden, the Netherlands, says it has raised €23 million ($30 million) in new equity financing. The company develops therapeutics using ribonucleic acid (RNA) modulation to address rare diseases, including Duchenne muscular dystrophy, myotonic dystrophy, and Huntington’s disease. The funding round is led by New Enterprise Associates in Menlo Park, California,…

  • Novo Nordisk to Add New Diabetes R&D Center in Seattle

    The Danish drug maker Novo Nordisk says it will add a new research facility to study type 1 diabetes in Seattle, Washington. The lab is expected to open this summer and employ 20 researchers on the site of its current inflammation research center. Novo Nordisk says the new lab will conduct translational studies that combine…

  • First Results Show Safety of Stem Cell Eye Transplants

    Early results from two clinical trials show the safety of retinal cells derived from human embryonic stems cells (hESCs) to treat chronic eye diseases. The results from two patients, one in each trial conducted by the biotechnology company Advanced Cell Technology (ACT) in Marlborough, Massachusetts, were published online in the journal The Lancet. The clinical…

  • Comparative Research Institute Agenda Posted for Comment

    The Patient-Centered Outcomes Research Institute (PCORI) today released for comment a draft of its research priorities and agenda, which it says will guide future funding announcements. The institute, established by the 2010 Affordable Care Act (health care reform law) to fund comparative effectiveness and related research, is accepting comments on the document through 15 March…

  • U.S. VC Investments Up for 2011, Flat for Science Companies

    Venture capital (VC) investors in the U.S. increased in 2011 compared to 2010, both in terms of numbers of deals and amount of money invested. However, the fourth quarter of the year was an unusually slow period, according to Dow Jones VentureSource that compiled the data, and consumer Web companies appeared to benefit from the…

  • Aspirin Could Help Prevent Cervical Cancer in Women with HIV

    Research by global health investigators and cancer specialists suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women. The findings by a team from New York-Presbyterian Hospital and Weill Cornell Medical Center in New York, with colleagues from Qatar and Haiti, are published in the current issue…